EXPO (Exponent) Marketable Securities: $0.0 Mil (As of Mar. 2026)


EXPO Exponent Inc EXPO
83 GF Score
Price $62.04
GF Value $92.48
Valuation Significantly Undervalued
! 3 Warning Signs
View Full Analysis

What is Exponent Marketable Securities?

Exponent EXPO +1.45% 83 Marketable Securities is $0.0 Mil as of Mar. 2026. GuruFocus rates EXPO with a GF Score™ of 83/100 and a GF Value™ of $92.48 (Significantly Undervalued). The stock has 3 warning signs investors should review.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Exponent's Marketable Securities for the quarter that ended in Mar. 2026 was $0.0 Mil.


Exponent  (NAS:EXPO) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".


Exponent Marketable Securities Related Terms


Exponent Marketable Securities Historical Data

* Premium members only.

The historical data trend for Exponent's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Exponent Marketable Securities Chart

Exponent Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Marketable Securities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Exponent Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
EXPO
83GF Score
Exponent Inc EXPO
Marketable Securities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Exponent Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Frequently Asked Questions Learn more about Marketable Securities →
What does a Marketable Securities of $0.0 Mil mean?
Exponent (EXPO) has a Marketable Securities of $0.0 Mil as of Mar. 2026. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Exponent and its competitors.
Is Exponent's Marketable Securities too high?
Exponent's current Marketable Securities is $0.0 Mil. Overall, Exponent has a GF Score™ of 83/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Exponent's Marketable Securities compare to CDNL and TPC?
Exponent's Marketable Securities of $0.0 Mil can be compared against companies in the Construction industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Marketable Securities for a Construction company?
A good Marketable Securities depends on the Construction industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Marketable Securities mean?
A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Exponent and its competitors. Exponent's current Marketable Securities is $0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Exponent stock overvalued right now?
Based on GuruFocus' analysis, Exponent (EXPO) is currently considered Significantly Undervalued. The stock's GF Value™ is $92.48, compared to a current price of $62.04 — trading 32.9% below its estimated fair value. The current Marketable Securities is $0.0 Mil. Exponent's overall GF Score™ is 83/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Marketable Securities calculated?
Marketable Securities is calculated from a company's financial statements. For Exponent (EXPO), the current Marketable Securities is $0.0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Exponent (EXPO) Overvalued in 2026?

Based on GuruFocus' analysis, Exponent stock appears to be undervalued. The current stock price of $62.04 is trading 32.9% below its estimated GF Value™ of $92.48. GuruFocus considers Exponent to be Significantly Undervalued.

Key valuation signals for EXPO:

  • Marketable Securities: $0.0 Mil
  • GF Value™: $92.48 vs. price of $62.04 (32.9% below fair value)
  • GF Score™: 83/100 with 3 warning signs

No single metric tells the full story. See the EXPO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Exponent Business Description

Other Exchanges EP5:Germany
Address 149 Commonwealth Drive, Menlo Park, CA, USA, 94025
Exponent Inc is a science and engineering consulting firm that provides solutions to complex problems. The company's consultant team is composed of scientists, physicians, engineers, as well as business and regulatory consultants. The company currently operates through two segments. The engineering and other scientific segments, which account for the majority of revenue, provide servicing encompassing biomechanics, biomedical engineering, buildings and structures, civil engineering, construction consulting, etc. The environmental and health segment covers chemical regulation and food safety, ecological and biological sciences, environmental and earth sciences and others. The company generates almost all of its revenues from America.
83GF Score

Get the complete analysis for EXPO

Marketable Securities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$62.04
Price
$92.48
GF Value